Una píldora anticonceptiva masculina no hormonal nueva es altamente efectiva en los ratones y podrían comenzar las pruebas en humanos en el 2022, según los investigadores.
Related Posts
Obamacare May Have Helped Lower Suicide Rates
THURSDAY, June 16, 2022 (HealthDay News) -- Suicide rates are rising more slowly...
Johnson & Johnson Agrees to $8.9 Billion Settlement in Talcum Powder Lawsuit
WEDNESDAY, April 5, 2023 (HealthDay News) -- Tens of thousands of people suing...
PTSD, Other Mental Health Ills Haunt Gunshot Survivors
TUESDAY, May 23, 2023 (HealthDay News) -- For people who survive gunshot wounds,...
Music Lovers’ Physiology ‘Synchronizes’ at Classical Music Concerts
FRIDAY, Oct. 6, 2023 (HealthDay News) -- New research suggests that concert...